glp-1 receptor agonists and cancer risk in adults with obesity agonist use obese nondiabetic Gastrointestinal effect and adverse effects
Description
[DOI] [PubMed] [Google Scholar] 559.Schafer S.A., Tschritter O., Machicao F., Thamer C., Stefan N., Gallwitz B
That finding surprised many researchers and requires careful interpretation
Review Article: Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity Background More than 19 years after the first GLP1RA was introduced for type 2 diabetes and 10 years after its approval for obesity, innovations are expanding the use of GLP-1 medicines for metabolic disorders
GLP-1 Drug Risks and Side Effects GLP-1 drugs are associated with a wide variety of side effects
doi: 10.2337/db14-0302
Is Ozempic Always the Best GLP1 Option for Weight Loss
